| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |